 | • レポートコード：QYR9ST04781 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、冠動脈疾患治療薬の世界市場について調査・分析し、冠動脈疾患治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ベータ遮断薬、カルシウムチャネル遮断薬、硝酸塩、ACE阻害薬、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の冠動脈疾患治療薬市場動向 ・主要企業別マーケットシェア ・冠動脈疾患治療薬の種類別市場規模2014-2019 （ベータ遮断薬、カルシウムチャネル遮断薬、硝酸塩、ACE阻害薬、その他） ・冠動脈疾患治療薬の用途別市場規模2014-2019 （病院、診療所、その他） ・冠動脈疾患治療薬の北米市場：主要企業・種類別/用途別市場規模 ・冠動脈疾患治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・冠動脈疾患治療薬の中国市場：主要企業・種類別/用途別市場規模 ・冠動脈疾患治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・冠動脈疾患治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・冠動脈疾患治療薬のインド市場：主要企業・種類別/用途別市場規模 ・冠動脈疾患治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Novartis、GlaxoSmithKline、Merck、AstraZeneca、Gilead、Bayer、Bristol-Myers Squibb、Mylan、Teva Pharmaceutical Industries） ・冠動脈疾患治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death.Our research analysis on the global coronary artery disease therapeutics market has identified that the increase in number of chronic diseases will be one of the major factors that will have a positive impact on this market’s growth during the next few years.
The consumption of drugs for cardiovascular disease (CAD) in the Americas is increasing due to the rising incidences of heart disease in the region. The region is heavily investing in the healthcare sector, which in turn, will drive the coronary artery disease therapeutics market’s growth in the region. The US is the major revenue generator in the region due to the presence of the pharmaceutical giants and high prevalence rate of CAD.
In 2018, the global Coronary Artery Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Coronary Artery Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Coronary Artery Disease Therapeutics development in United States, Europe and China.
The key players covered in this study
Pfizer
Novartis
GlaxoSmithKline
Merck
AstraZeneca
Gilead
Bayer
Bristol-Myers Squibb
Mylan
Teva Pharmaceutical Industries
Market segment by Type, the product can be split into
Beta-Blockers
Calcium Channel Blockers
Nitrates
ACE Inhibitors
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Coronary Artery Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Coronary Artery Disease Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Coronary Artery Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Beta-Blockers
1.4.3 Calcium Channel Blockers
1.4.4 Nitrates
1.4.5 ACE Inhibitors
1.4.6 Others
1.5 Market by Application
1.5.1 Global Coronary Artery Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Coronary Artery Disease Therapeutics Market Size
2.2 Coronary Artery Disease Therapeutics Growth Trends by Regions
2.2.1 Coronary Artery Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Coronary Artery Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Coronary Artery Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Coronary Artery Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Coronary Artery Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Coronary Artery Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Coronary Artery Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Coronary Artery Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Coronary Artery Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Coronary Artery Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Coronary Artery Disease Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Coronary Artery Disease Therapeutics Market Size (2014-2019)
5.2 Coronary Artery Disease Therapeutics Key Players in United States
5.3 United States Coronary Artery Disease Therapeutics Market Size by Type
5.4 United States Coronary Artery Disease Therapeutics Market Size by Application
6 Europe
6.1 Europe Coronary Artery Disease Therapeutics Market Size (2014-2019)
6.2 Coronary Artery Disease Therapeutics Key Players in Europe
6.3 Europe Coronary Artery Disease Therapeutics Market Size by Type
6.4 Europe Coronary Artery Disease Therapeutics Market Size by Application
7 China
7.1 China Coronary Artery Disease Therapeutics Market Size (2014-2019)
7.2 Coronary Artery Disease Therapeutics Key Players in China
7.3 China Coronary Artery Disease Therapeutics Market Size by Type
7.4 China Coronary Artery Disease Therapeutics Market Size by Application
8 Japan
8.1 Japan Coronary Artery Disease Therapeutics Market Size (2014-2019)
8.2 Coronary Artery Disease Therapeutics Key Players in Japan
8.3 Japan Coronary Artery Disease Therapeutics Market Size by Type
8.4 Japan Coronary Artery Disease Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Coronary Artery Disease Therapeutics Market Size (2014-2019)
9.2 Coronary Artery Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Type
9.4 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Application
10 India
10.1 India Coronary Artery Disease Therapeutics Market Size (2014-2019)
10.2 Coronary Artery Disease Therapeutics Key Players in India
10.3 India Coronary Artery Disease Therapeutics Market Size by Type
10.4 India Coronary Artery Disease Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Coronary Artery Disease Therapeutics Market Size (2014-2019)
11.2 Coronary Artery Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Coronary Artery Disease Therapeutics Market Size by Type
11.4 Central & South America Coronary Artery Disease Therapeutics Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Coronary Artery Disease Therapeutics Introduction
12.1.4 Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Coronary Artery Disease Therapeutics Introduction
12.2.4 Novartis Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Coronary Artery Disease Therapeutics Introduction
12.3.4 GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Coronary Artery Disease Therapeutics Introduction
12.4.4 Merck Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Coronary Artery Disease Therapeutics Introduction
12.5.4 AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Gilead
12.6.1 Gilead Company Details
12.6.2 Company Description and Business Overview
12.6.3 Coronary Artery Disease Therapeutics Introduction
12.6.4 Gilead Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.6.5 Gilead Recent Development
12.7 Bayer
12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Coronary Artery Disease Therapeutics Introduction
12.7.4 Bayer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.7.5 Bayer Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Coronary Artery Disease Therapeutics Introduction
12.8.4 Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Mylan
12.9.1 Mylan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Coronary Artery Disease Therapeutics Introduction
12.9.4 Mylan Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.9.5 Mylan Recent Development
12.10 Teva Pharmaceutical Industries
12.10.1 Teva Pharmaceutical Industries Company Details
12.10.2 Company Description and Business Overview
12.10.3 Coronary Artery Disease Therapeutics Introduction
12.10.4 Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.10.5 Teva Pharmaceutical Industries Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Coronary Artery Disease Therapeutics Key Market Segments
Table Key Players Coronary Artery Disease Therapeutics Covered
Table Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Coronary Artery Disease Therapeutics Market Size Market Share by Type 2014-2025
Figure Beta-Blockers Figures
Table Key Players of Beta-Blockers
Figure Calcium Channel Blockers Figures
Table Key Players of Calcium Channel Blockers
Figure Nitrates Figures
Table Key Players of Nitrates
Figure ACE Inhibitors Figures
Table Key Players of ACE Inhibitors
Figure Others Figures
Table Key Players of Others
Table Global Coronary Artery Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Coronary Artery Disease Therapeutics Report Years Considered
Table Global Coronary Artery Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Coronary Artery Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Coronary Artery Disease Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Coronary Artery Disease Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Coronary Artery Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Coronary Artery Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Coronary Artery Disease Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Coronary Artery Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Coronary Artery Disease Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Coronary Artery Disease Therapeutics Market Share by Manufacturers in 2018
Table Global Coronary Artery Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Coronary Artery Disease Therapeutics Product/Solution/Service
Table Date of Enter into Coronary Artery Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Coronary Artery Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Coronary Artery Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Coronary Artery Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Coronary Artery Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Coronary Artery Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Coronary Artery Disease Therapeutics Revenue Market Share by Application in 2018
Figure United States Coronary Artery Disease Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Coronary Artery Disease Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Coronary Artery Disease Therapeutics Market Share (2018-2019)
Table United States Coronary Artery Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Coronary Artery Disease Therapeutics Market Share by Type (2014-2019)
Table United States Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Coronary Artery Disease Therapeutics Market Share by Application (2014-2019)
Figure Europe Coronary Artery Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Coronary Artery Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Coronary Artery Disease Therapeutics Market Share (2018-2019)
Table Europe Coronary Artery Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Coronary Artery Disease Therapeutics Market Share by Type (2014-2019)
Table Europe Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Coronary Artery Disease Therapeutics Market Share by Application (2014-2019)
Figure China Coronary Artery Disease Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Coronary Artery Disease Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Coronary Artery Disease Therapeutics Market Share (2018-2019)
Table China Coronary Artery Disease Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Coronary Artery Disease Therapeutics Market Share by Type (2014-2019)
Table China Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Coronary Artery Disease Therapeutics Market Share by Application (2014-2019)
Figure Japan Coronary Artery Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Coronary Artery Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Coronary Artery Disease Therapeutics Market Share (2018-2019)
Table Japan Coronary Artery Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Coronary Artery Disease Therapeutics Market Share by Type (2014-2019)
Table Japan Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Coronary Artery Disease Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Coronary Artery Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Coronary Artery Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Coronary Artery Disease Therapeutics Market Share (2018-2019)
Table Southeast Asia Coronary Artery Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Coronary Artery Disease Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Coronary Artery Disease Therapeutics Market Share by Application (2014-2019)
Figure India Coronary Artery Disease Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Coronary Artery Disease Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Coronary Artery Disease Therapeutics Market Share (2018-2019)
Table India Coronary Artery Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Coronary Artery Disease Therapeutics Market Share by Type (2014-2019)
Table India Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Coronary Artery Disease Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Coronary Artery Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Coronary Artery Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Coronary Artery Disease Therapeutics Market Share (2018-2019)
Table Central & South America Coronary Artery Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Coronary Artery Disease Therapeutics Market Share by Type (2014-2019)
Table Central & South America Coronary Artery Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Coronary Artery Disease Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Merck Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Gilead Company Details
Table Gilead Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure Gilead Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Gilead Recent Development
Table Bayer Company Details
Table Bayer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Mylan Company Details
Table Mylan Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Mylan Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Global Coronary Artery Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Coronary Artery Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Coronary Artery Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Coronary Artery Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Coronary Artery Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Coronary Artery Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Coronary Artery Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Coronary Artery Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Coronary Artery Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Coronary Artery Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Coronary Artery Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Coronary Artery Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Coronary Artery Disease Therapeutics Market Size by Product in 2025
Table Global Coronary Artery Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Coronary Artery Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Coronary Artery Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
冠動脈バイパス術の世界市場：市場規模・現状・予測 Coronary artery bypass grafting (CABG) is a type of bypass surgery that is used to create a new path for blood to flow to the heart. This is used for patients who have severe coronary heart disease. CABG is the most common type of open heart surgery in the United States. Deskbound lifestyle, anxiety…- 急性冠症候群（ACS）治療の世界市場：インサイト・予測 ACS or Acute coronary syndrome refers to the set of conditions which occurs on account of decreasing flow of blood in coronary arteries owing to which the heart muscle is not able to function. There are various symptoms associated with this condition. The most commonly occurring symptom includes che…
- 世界のベアメタル冠動脈ステント市場：専門的調査 Bare Metal Coronary Artery Stent is a stent without a coating or covering.It is a mesh-like tube of thin wire. The global Bare Metal Coronary Artery Stent market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This rep…
- アルツハイマー病治療薬の世界市場：市場規模・現状・予測 Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 非アルコール性脂肪性肝疾患治療薬の世界市場：市場規模・現状・予測 Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …